Similar articles

• [Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma].

  Yamashiki M, Kosaka Y. Yamashiki M, et al. Rinsho Byori. 1989 Feb;37(2):118-21. Rinsho Byori. 1989. PMID: 2471846 Japanese. No abstract available.
• [Follow-up studies on hepatoma developing from liver cirrhosis].

  Sakai T, Kishikawa Y. Sakai T, et al. Nihon Naika Gakkai Zasshi. 1991 Oct 10;80(10):1637-44. Nihon Naika Gakkai Zasshi. 1991. PMID: 1723090 Japanese. No abstract available.
• [Is detection of primary hepatocellular carcinoma in cirrhosis useful?].

  Dumas O, Barthélémy C, Audigier JC. Dumas O, et al. Gastroenterol Clin Biol. 1990;14(10):715-26. Gastroenterol Clin Biol. 1990. PMID: 1702073 Review. French. No abstract available.
• The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.

  Brunello F, Marcarino C, Pasquero P, Gastaldi P, Gonella S, Martini S, Calcamuggi G, Emanuelli G. Brunello F, et al. Ital J Gastroenterol. 1993 Jan;25(1):9-12. Ital J Gastroenterol. 1993. PMID: 7679014
• [Analysis of factors related to prognosis in patients with chronic hepatitis type C--clinical laboratory data].

  Matsumoto A, Tanaka E, Kiyosawa K. Matsumoto A, et al. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):430-3. Nihon Rinsho. 2004. PMID: 15359837 Review. Japanese. No abstract available.